logo
logo

Uk Biotech Oxford Nanopore Plans London Ipo, Seeks £300M Funding

Uk Biotech Oxford Nanopore Plans London Ipo, Seeks £300M Funding

09/20/21, 12:14 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/GB.svgunited kingdom
Money raised
£300 million
DNA-sequencing company Oxford Nanopore Technologies provides rapid COVID-19 tests to the NHS in Britain. Recently, the company announced that it will start trading on the London stock exchange and aims to raise £300 million from Oracle Group, which will increase its valuation to £2.4 billion.

Company Info

Company
Oxford Nanopore
Location
united kingdom
Additional Info
Welcome to Oxford Nanopore technologies. Our goal is to enable the analysis of any living thing, by any person, in any environment. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION.